Insider Cluster (5 insiders) ·Filed Jul 20, 2026

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 5 insiders, $0.7M total
Actionable Insight • Neutral

The insider selling cluster is too small in dollar terms to warrant a bearish read-through. Monitor the next 10-Q for any fundamental deterioration, but this cluster alone does not signal material insider concern.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
CLOV ▼ -11.69% at T+20d
NEUTRAL call ✗ call lost -11.69% · α vs SPY -14.25% · entry $4.79 → $4.23
Next anchor: T+60d in 11d
Latest observation: T+49 -46.72% FF3 residual α
Entry anchored
Jul 20, 03:59 PM ET
via exchange tick
T+1d
-2.51%
call -2.51% · α -2.39%
$4.67
settled 2mo ago
T+5d
-10.86%
call -10.86% · α -9.63%
$4.27
settled 2mo ago
T+20d
-11.69%
call -11.69% · α -14.25%
$4.23
settled 7w ago
T+60d
—
call — · α —
—
in 11d

Price Chart

Loading chart...

Executive Summary

Five CLOV insiders, including the CEO, CEO of Medicare Advantage, CEO of Counterpart Health, Chief Legal Officer, and Interim CFO, sold a total of $683K in open-market sales over a 7-day window. While the cluster includes multiple C-suite executives, the total dollar value is only ~0.03% of the company's $2.4B market cap, making it a trivial and routine event. The historical performance data shows a 25% win rate on prior CLOV reports, and the calibration data indicates that high-impact scores on this ticker have historically underperformed, reinforcing a neutral stance.

Key Financial Metrics

Direction
selling
Total Value
$683.0K
Insiders
5

Key Facts

  • Five insiders sold shares in a 7-day window ending July 20, 2026.
  • Total open-market sales: $683K, representing ~0.03% of CLOV's $2.4B market cap.
  • Sellers include CEO Andrew Toy ($293K), Chief Legal Officer Karen Soares ($233K), and three other C-suite executives.
  • The cluster is too small relative to market cap to be material; insider sales are generally weak predictors.
  • Historical calibration shows high-impact scores on CLOV have a poor track record, supporting a low impact score.

Financial Impact

Total insider sales of $683K, or ~0.03% of market cap, are immaterial.

dilution

Risk Factors

  • Insider sales could accelerate if the stock rallies further, but current volume is trivial.
  • No immediate catalyst identified; the cluster is likely liquidity-driven (e.g., tax planning, diversification).

Market Snapshot

Exchange
Nasdaq
Sector
Hospital & Medical Service Plans
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CLOV-1784584168900
18 reports for CLOV
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+5▲ +2.36%Aug 17, 2026
Filters
Rows
Reports for CLOV — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 2/10
$4.56 $4.57▲ +0.22%▼ −2.34%$4.41 (−3.40%)
Aug 17, 2026
6w ago
Insider Cluster
BEARISH ★ 5/10
$4.23 $4.13▲ +2.36%▲ +2.16%$4.41 (−4.14%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 4/10
$4.39 $4.23▼ −3.64%▼ −3.24%$4.41 (+0.34%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.79 $4.27▼ −10.86%▼ −9.63%$4.41 (−8.04%)
Jul 17, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.68 $4.40▼ −5.98%▼ −5.85%$4.41 (−5.88%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$5.00 $4.82▼ −3.60%▼ −4.15%$4.41 (−11.90%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.80 $5.21▲ +8.54%▲ +9.58%$4.41 (−8.23%)
Showing 10 of 18

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 20, 2026